Company
Heligenics
High content screening for biologic drugs
- Status
- Operatingas of 2026-09-20
- Business model
- B2B
- Headquarters
- Las Vegas, NV, United States
- Founded
- 2016
- Customers
- Pharma and Biotech
- heligenics.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- X (opens in a new tab)
- Crunchbase (opens in a new tab)
- Press page (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
Heligenics is a biotechnology company dedicated to accelerating and de-risking biologics discovery by delivering unprecedented functional insights at massive scale.
Funding snapshot
- Total raised
- $6MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Grant2025-02
Funding rounds
- Grant
- 2025-02
- Round, 2024
- $2.6M2024-08-23, SEC form D sold, 8 investors
- Grant
- 2023-02
- Round, 2022
- $2.2M2022-06-09, SEC form D sold, 12 investors
- Round, 2020
- $1.2M2020-03-31, SEC form D sold, 39 investors
Products
- Other
- GigaAssay
Loading relationship preview